Eli Lilly and Company logo

Eli Lilly and Company LLY

$ 1 273.46 -1.11%
report update icon

Quarterly report 2026-Q2
added 08-05-2026

Country

usaUSA

IPO year

-

Industry

Biotechnology

Stock Exchange

NYSESPB

Shares

897 M

Market Cap[1]

$ 1.14 T

EBITDA (LTM)

$ 2 B

P/E (LTM)

49.972174

P/S (LTM)

15.822899

EPS (LTM)

23.0

Eli Lilly and Company is one of the world's largest pharmaceutical companies, specializing in the development, manufacturing, and sale of innovative drugs for the treatment of various diseases.

The company was founded in 1876 in Indianapolis, Indiana and has since become a leader in the pharmaceutical industry. Eli Lilly and Company develops and manufactures a wide range of drugs, including those for diabetes, cancer, mental disorders, Alzheimer's disease, and other illnesses.

One of the company's most well-known developments is insulin, which was created in 1923. This drug became the first effective treatment for diabetes and has saved millions of lives worldwide.

Eli Lilly and Company actively invests in research and development of new drugs to help patients worldwide fight various diseases. The company also aims to improve the quality of life for patients by providing them with access to high-quality drugs. Is a global company with operations in more than 125 countries. The company cares about its employees and society as a whole, participating in various charitable projects and social responsibility programs.

Overall, is one of the most successful and innovative companies in the pharmaceutical industry. Its products help millions of people worldwide overcome difficulties associated with various diseases and improve their quality of life.

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
- - - MOEX russiaRussia
ММЦБ ММЦБ
GEMA
- - - MOEX russiaRussia
Lyra Therapeutics Lyra Therapeutics
LYRA
- - $ 24.9 M Nasdaq Global Market usaUSA
Завод ДИОД Завод ДИОД
DIOD
- - - MOEX,SPB russiaRussia
Фармсинтез Фармсинтез
LIFE
- - - MOEX russiaRussia
ОЗОН Фармацевтика ОЗОН Фармацевтика
OZPH
- - - MOEX russiaRussia
Промомед Промомед
PRMD
- - - MOEX russiaRussia
Brickell Biotech Brickell Biotech
BBI
- -5.38 % $ 6.06 M Nasdaq Capital Market usaUSA
Applied Therapeutics Applied Therapeutics
APLT
- - $ 8.42 M Nasdaq Global Market,SPB usaUSA
ESSA Pharma ESSA Pharma
EPIX
- - $ 8.86 M Nasdaq Capital Market canadaCanada
Generation Bio Co. Generation Bio Co.
GBIO
- - $ 344 M Nasdaq Global Select Market usaUSA
Clearside Biomedical Clearside Biomedical
CLSD
- - $ 25.3 M Nasdaq Global Market usaUSA
Merus N.V. Merus N.V.
MRUS
- - $ 5.78 B Nasdaq Global Select Market niderlandNiderland
RAPT Therapeutics RAPT Therapeutics
RAPT
- - $ 2.36 B Nasdaq Global Select Market usaUSA
Exicure Exicure
XCUR
$ 1.05 -7.08 % $ 6.61 M Nasdaq Capital Market usaUSA
Cellectis S.A. Cellectis S.A.
CLLS
$ 0.98 0.51 % $ 98.3 M Nasdaq Global Market franceFrance
AbCellera Biologics AbCellera Biologics
ABCL
$ 11.82 3.96 % $ 3.53 B Nasdaq Global Select Market canadaCanada
Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals
ARWR
$ 58.02 -0.58 % $ 7.76 B Nasdaq Global Select Market,SPB usaUSA
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
$ 55.95 -1.2 % $ 10.7 B Nasdaq Global Select Market,SPB usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
$ 29.25 0.97 % $ 1.94 B Nasdaq Global Select Market usaUSA
CollPlant Biotechnologies Ltd. CollPlant Biotechnologies Ltd.
CLGN
$ 3.67 1.38 % $ 44.8 M Nasdaq Capital Market israelIsrael
Jaguar Health Jaguar Health
JAGX
$ 2.04 -5.12 % $ 4.76 M Nasdaq Capital Market usaUSA
Protalix BioTherapeutics Protalix BioTherapeutics
PLX
$ 2.55 -0.58 % $ 200 M NYSE American israelIsrael
uniQure N.V. uniQure N.V.
QURE
$ 22.43 -2.94 % $ 1.29 B Nasdaq Global Select Market niderlandNiderland
Stoke Therapeutics Stoke Therapeutics
STOK
$ 25.04 -2.57 % $ 1.48 B Nasdaq Global Select Market,SPB usaUSA
Xencor Xencor
XNCR
$ 25.18 -2.55 % $ 1.87 B Nasdaq Global Select Market,SPB usaUSA
Annexon Annexon
ANNX
$ 3.75 -1.57 % $ 582 M Nasdaq Global Select Market usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
$ 1.78 -2.73 % $ 2.93 M NYSE American israelIsrael
Incyte Corporation Incyte Corporation
INCY
$ 115.71 -1.04 % $ 22.6 B Nasdaq Global Select Market,SPB usaUSA
Mesoblast Limited Mesoblast Limited
MESO
$ 12.28 -2.15 % $ 14.8 B Nasdaq Global Select Market australiaAustralia
MeiraGTx Holdings plc MeiraGTx Holdings plc
MGTX
$ 9.21 -5.73 % $ 741 M Nasdaq Global Select Market usaUSA
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
VRTX
$ 523.93 -2.1 % $ 134 B Nasdaq Global Select Market,SPB usaUSA
Abeona Therapeutics Abeona Therapeutics
ABEO
$ 4.4 -1.57 % $ 233 M Nasdaq Capital Market usaUSA
AbbVie AbbVie
ABBV
$ 285.64 0.24 % $ 505 B NYSE,SPB usaUSA
AIM ImmunoTech AIM ImmunoTech
AIM
$ 0.16 -4.11 % $ 259 K NYSE American usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
$ 0.57 0.84 % $ 147 M Nasdaq Global Market usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
$ 4.2 -0.24 % $ 805 M Nasdaq Global Select Market canadaCanada
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
$ 19.73 -2.86 % $ 3.32 B Nasdaq Global Select Market,SPB usaUSA
ADC Therapeutics SA ADC Therapeutics SA
ADCT
$ 1.44 -9.72 % $ 183 M NYSE schweizSchweiz
Adaptive Biotechnologies Corporation Adaptive Biotechnologies Corporation
ADPT
$ 25.51 4.51 % $ 3.87 B Nasdaq Global Select Market,SPB usaUSA
EyePoint Pharmaceuticals EyePoint Pharmaceuticals
EYPT
$ 0.4 -5.51 % $ 29.3 K Nasdaq Global Market usaUSA
Seagen Seagen
SGEN
- - $ 42.2 B Nasdaq Global Select Market,SPB usaUSA
Agios Pharmaceuticals Agios Pharmaceuticals
AGIO
$ 37.0 -0.51 % $ 2.14 B Nasdaq Global Select Market,SPB usaUSA
Oncternal Therapeutics Oncternal Therapeutics
ONCT
- -24.12 % $ 1.56 M Nasdaq Capital Market usaUSA
Iterum Therapeutics Iterum Therapeutics
ITRM
- - $ 591 K Nasdaq Global Select Market irlandaIrlanda
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
- - $ 26.5 M Nasdaq Global Select Market usaUSA
Achieve Life Sciences Achieve Life Sciences
ACHV
$ 6.49 -0.15 % $ 283 M Nasdaq Capital Market usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
- - $ 2.17 B Nasdaq Global Market usaUSA
Geron Corporation Geron Corporation
GERN
$ 1.12 -0.88 % $ 747 M Nasdaq Global Select Market usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
- - $ 401 M Nasdaq Global Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.